ReviewJournal for immunotherapy of cancer2022

Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy.

Yeonggyeong Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.